Abivax SA
ABVX · NYSE
$88.01−$2.22 (−2.46%)TodayMarket closed ·
Prev close $90.23
About ABVX
- Employees
- 80
- Headquarters
- Paris, Ile-De-France
- Listed
- Jun 26, 2015
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- abivax.com
Leadership
| Name | Title | Since |
|---|---|---|
| Sylvie Gregoire | — | — |
| Marc De Garidel | — | 2023 |
| Didier Blondel | — | — |
| Ida Hatoum | — | — |
| Jerome Denis | — | 2024 |
| Hema Keshava | — | — |
| Patrick Malloy | — | — |
| Nadege Briancon-eris | — | — |
| Jennifer Fine | — | — |
| Douglas Jacobstein | — | — |
| Mary Mantock | — | — |
| Didier Scherrer | — | 2023 |
| Sophie Lacourrege | — | — |
| Chris Rabbat | — | — |
| Kevin Shan | — | — |
| Fabio Cataldi | — | — |
| Pierre Courteille | — | 2023 |
| David Zhang | — | — |
| Dominik Hoechli | — | — |
| Kinam Hong | — | — |
| Corinna Zur Bonsen-Thomas | — | 2023 |
| Troy Ignelzi | — | — |
| June Lee | — | — |
| Camilla Soenderby | — | — |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.